NUTEX HEALTH INC (NUTX) Forecast, Price Target & Analyst Ratings

NASDAQ:NUTX • US67079U3068

Current stock price

108.91 USD
+0.67 (+0.62%)
Last:

Analyst forecast overview

View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for NUTEX HEALTH INC (NUTX).

Forecast Snapshot

Consensus Price Target

Price Target
$226.10
+ 107.60% Upside
→ Price target details

Next Earnings Forecast

Earnings Estimate
Release Date
May 11, 2026
Period
Q1 / 2026
EPS Estimate
$4.98
Revenue Estimate
232.45M
→ Full earnings forecast details

ChartMill Buy Consensus

Rating
82.22%
Weighted Analyst Rating Score
→ Analyst Ratings details

Price Target Details & History

Consensus Price Target and Range

Mean target
$226.10
Upside
+ 107.60%
From current price of $108.91 to mean target of $226.10, Based on 9 analyst forecasts
Low
$151.50
Median
$219.30
High
$315.00

Price Target Revisions

1 Month
-11.33%
3 Months
-11.33%

Price Target Summary

9 Wall Street analysts provided a forecast for the next 12 months for NUTX. The average price target is 226.1 USD. This implies a price increase of 107.6% is expected in the next year compared to the current price of 108.91.
The average price target has been revised downward by 11.33% in the past 3 months.
→ Find peer stocks trading 30% below analyst price target

Analyst Ratings & History

Current Analyst Ratings

NUTX Current Analyst RatingNUTX Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 1 2 3 4 5

Analyst Ratings History

NUTX Historical Analyst RatingsNUTX Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -19 -17 -15 -13 -11 -9 -7 -5 -3 -1 2 4 6 8

Analyst Ratings Consensus

ChartMill Buy Consensus
82.22%
NUTX was analyzed by 9 analysts. The buy percentage consensus is at 82. So analysts seem to be very confident about NUTX.
In the previous month the buy percentage consensus was at a similar level.
NUTX was analyzed by 9 analysts. More opinions would make the average more meaningful.
→ Find peer stocks with a buy consensus above 85%

Recent Upgrades & Downgrades

DateFirmActionFrom → To
2025-08-26Maxim GroupMaintains Buy -> Buy
2025-05-20Maxim GroupMaintains Buy -> Buy
2025-05-15BenchmarkMaintains Buy -> Buy
2025-04-08Maxim GroupMaintains Buy -> Buy
2025-02-13Maxim GroupMaintains Buy -> Buy
2024-11-12BenchmarkMaintains Buy -> Buy
2024-11-12Maxim GroupMaintains Buy -> Buy
2024-09-18Maxim GroupInitiate Buy
2024-08-21BenchmarkMaintains Buy -> Buy
2024-01-25BenchmarkMaintains Buy -> Buy
2023-11-14BenchmarkMaintains Buy -> Buy
2023-08-29BenchmarkReiterate Buy -> Buy
2023-05-17BenchmarkMaintains Buy -> Buy
2023-03-09BenchmarkReiterate Buy
2022-12-23BenchmarkInitiate Buy

Next Earnings Forecast Details

Next Earnings Details

Release Date
May 11, 2026
Period
Q1 / 2026
EPS Estimate
$4.98
Revenue Estimate
232.45M
Revenue Q2Q
9.76%
EPS Q2Q
94.44%
Number of Analysts
5

Next Earnings Revisions

Revenue (1 Month)
-1.89%
Revenue (3 Months)
-8.67%
EPS (1 Month)
-3.05%
EPS (3 Months)
-4.78%

Next Earnings Summary

NUTX is expected to report earnings on 5/11/2026. The consensus EPS estimate for the next earnings is 4.98 USD and the consensus revenue estimate is 232.45M USD.
The next earnings revenue estimate has been revised downward by 8.67% in the past 3 months. Downward revisions are a negative sign and indicate that analysts are more pessimistic about the next earnings compared to 3 months ago.
→ Find peers expecting at least 20% revenue growth next quarter

Full Analyst Estimates 2026 - 2027

Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates

2023 2024 2025 2026 2027
Revenue
YoY % growth
NUTX revenue by date.NUTX revenue by date.
247.646M
12.93%		479.949M
93.80%		875.257M
82.36%		928.83M
6.12%		966.36M
4.04%
EBITDA
YoY % growth
NUTX ebitda by date.NUTX ebitda by date.
16.3M
90.58%		156.678M
861.21%		296.155M
89.02%		273.49M
-7.65%		300.18M
9.76%
EBIT
YoY % growth
NUTX ebit by date.NUTX ebit by date.
-1.292M
71.78%		137.706M
10,758.36%		275.625M
100.15%		360.71M
30.87%		363.86M
0.87%
Operating Margin
NUTX operating margin by date.NUTX operating margin by date.
-0.52%28.69%31.49%38.83%37.65%
EPS
YoY % growth
NUTX eps by date.NUTX eps by date.
-4.50
95.61%		8.73
294.00%		9.10
4.24%		19.34
112.56%		23.17
19.78%

All data in USD

Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates

Q1 / 26 Q2 / 26 Q3 / 26 Q4 / 26
EPS
Q2Q % growth		4.98
94.44%		4.70
259.17%		4.64
-40.24%		5.04
191.06%
Revenue
Q2Q % growth		232.45M
9.76%		226.04M
-7.35%		226.4M
-15.46%		243.97M
60.85%
EBITDA
Q2Q % growth		70.416M
-8.91%		64.111M
45.64%		64.659M
-55.62%		74.337M
44.49%
EBIT
Q2Q % growth		86.526M
19.83%		81.483M
141.94%		81.241M
-37.68%		90.199M
191.74%

All data in USD

Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data

NUTX Yearly Revenue VS EstimatesNUTX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 200M 400M 600M 800M 1B
NUTX Yearly EPS VS EstimatesNUTX Yearly EPS VS EstimatesYearly EPS VS Estimates 2022 2023 2024 2025 2026 2027 0 20 -20 -40 -60 -80 -100

Long Term Forward Growth Forecast Summary

Long Term EPS Growth (CAGR)

EPS Next 3 Year
N/A
EPS Next 5 Year
N/A

Long Term Revenue Growth (CAGR)

Revenue Next 3 Year
N/A
Revenue Next 5 Year
N/A

Long Term EBIT Growth (CAGR)

EBIT Next 3 Year
N/A
EBIT Next 5 Year
N/A
→ Find peers expecting at least 20% CAGR revenue growth over the next 3 years

NUTEX HEALTH INC / NUTX Forecast FAQ

What is the average price target for NUTEX HEALTH INC (NUTX) stock?

9 analysts have analysed NUTX and the average price target is 226.1 USD. This implies a price increase of 107.6% is expected in the next year compared to the current price of 108.91.

When does NUTEX HEALTH INC (NUTX) report earnings?

NUTEX HEALTH INC (NUTX) will report earnings on 2026-05-11.

What are the consensus estimates for NUTEX HEALTH INC (NUTX) next earnings?

The consensus EPS estimate for the next earnings of NUTEX HEALTH INC (NUTX) is 4.98 USD and the consensus revenue estimate is 232.45M USD.